Table 1.
Baseline demographics and clinical characteristics.
|
BAV
n = 170 |
TAV
n = 201 |
P-value | |
|---|---|---|---|
| Age, yrs | 75.1 ± 6.6 | 76.9 ± 6.7 | 0.013 |
| Male | 97 (57.1) | 120 (59.7) | 0.607 |
| BMI, kg/m2 | 22.4 ± 3.3 | 22.6 ± 3.6 | 0.541 |
| STS PROM, % | 6.0 ± 3.7 | 7.1 ± 5.1 | 0.010 |
| Smoking | 24 (14.1) | 32 (15.9) | 0.629 |
| Dyslipidemia | 29 (17.1) | 41 (20.4) | 0.413 |
| Hypertension | 91 (53.5) | 121 (60.2) | 0.196 |
| Diabetes mellitus | 38 (22.4) | 44 (21.9) | 0.915 |
| Syncope | 20 (11.8) | 12 (6.0) | 0.048 |
| NYHA functional class | |||
| I - II | 20 (11.8) | 22 (10.9) | 0.804 |
| III | 84 (49.4) | 84 (41.8) | 0.142 |
| IV | 66 (38.8) | 95 (47.3) | 0.102 |
| Previous MI | 1 (0.6) | 5 (2.5) | 0.225 |
| Prior PCI | 12 (7.1) | 23 (11.4) | 0.209 |
| Prior CABG | 0 (0) | 3 (1.5) | 0.253 |
| Prior stroke | 6 (3.5) | 13 (6.5) | 0.676 |
| Prior pacemaker | 4 (2.4) | 5 (2.5) | 1.000 |
| Atrial fibrillation/flutter | 29 (17.1) | 38 (18.9) | 0.645 |
| PVD | 18 (10.6) | 33 (16.4) | 0.104 |
| COPD | 35 (20.6) | 50 (24.9) | 0.328 |
| LVEF, % | 52.7 ± 14.8 | 54.9 ± 13.7 | 0.261 |
Values are mean ± SD or number (%).
BMI, body mass index; CABG, coronary artery bypass grafting; COPD, Chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NYHA, New York Heart Association; PCI, percutaneous coronary intervention; PROM, Predicted Risk of Mortality; PVD, peripheral vascular diseases; STS, Society of Thoracic Surgeons.